Reverie Labs
YC W18Boston, US · Founded 2017 · 29 employees · Inactive · 5 known investors
Reverie Labs develops cancer treatments designed to cross the blood-brain barrier and treat tumors in the central nervous system.
AI & Machine LearningBiotechHealthtechAI-powered Drug DiscoveryMachine Learningin /reverie-labs/@reverielabs
Founders & leadership· Y Combinator alumni (W18)
Investors · 5
In the news
- Acquiring Reverie Labs Platform to Enhance AI-Driven Drug Discovery Capabilities for Customer Programs - Ginkgo Bioworksginkgobioworks.com · 2024
- Reverie Labs - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Reverie Labs raises 25Mseas.harvard.edu · 2021
- Reverie Labs Raises $25M in Series A Funding - FinSMEsfinsmes.com · 2021
- Reverie Labs raises $25 million for its AI drug discovery platform | VentureBeatventurebeat.com · 2021
- Reverie Labs Raises $25M Series A Round to Broaden Impact of its Computational Kinase Drug Discovery Platformprnewswire.com · 2021
- Startupsstartups.rip